HASSELT - February 21, 2025 - Digital health pioneers Inhealthcare and FibriCheck today announced the expansion of their partnership to bring hospital-grade heart monitoring into patients' homes through NHS virtual ward pathways. Inhealthcare has developed more than 150 clinically designed…
FibriCheck entered the U.S. market with FDA-approved heart monitoring technology 2024 was a transformative year for FibriCheck as we achieved FDA clearance (K232804) for our entire ecosystem, including our patient-facing app, AI-powered algorithm, and healthcare provider portal. The FDA-clearance allows…
We have added a new feature to FibriCheck that has been designed in order to support healthcare providers with their patient follow-up. Healthcare providers will now be able to log treatments (e.g. ablation, cardioversion, and medication) or diagnostics (e.g. Holter…
After a rigorous investigation procedure by the Food and Drug Administration, FibriCheck is now FDA-cleared (K232804). This is an important milestone which supports our further development in the U.S. market. The FDA-clearance allows us to improve current U.S. care pathways…
At FibriCheck, we are always innovating and working towards improved efficiency and innovation in heart healthcare. This year, we’ve made important strides towards those goals, as we worked on a variety of interesting projects together with our partners, and made…
Artificial intelligence is becoming increasingly important in all sectors, as it is a growing field with new possibilities emerging every day. As AI algorithms and technologies become more advanced, they can be implemented to optimise processes, make predictions, and provide…
Hasselt, Sep 30, 2022 - Extra Horizon, a leader in the Medical Backend-as-a-Service (MBaaS) market, has officially demerged from its parent company, Qompium nv. For almost a decade now, Qompium has been a leading pioneer in the Software as a…
Our acceptance into DigitalHealth.London’s Accelerator programme, gave us the opportunity to significantly increase our credibility and visibility with NHS stakeholders. At the same time, we also grew our understanding of UK Information Governance (IG) and cyber security requirements.
We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further accelerate the growth of both our business units. While keeping one eye on international growth, the FibriCheck app is also…
Hasselt, February 3, 2021 - Qompium, the pioneering Belgian digital health company, has received an additional 9 million euros in funding after a new capital round. With its business units FibriCheck (medical app which detects heart rhythm disorders) and Extra Horizon (secure,…